Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Inhibition of corneal neovascularization by recombinant adenovirus-mediated sFlk-1 expression

Journal Article · · Biochemical and Biophysical Research Communications
; ;  [1];  [2]; ; ; ; ;  [1]
  1. Central Experimental Laboratory, The First People's Hospital, Shanghai Jiaotong University, Shanghai 200080 (China)
  2. Technology Center, NeoTrident Technology Ltd., Beijing 100080 (China)

The interaction of vascular endothelial growth factor (VEGF) and its receptors (Flt-1, Flk-1/KDR) is correlated with neovascularization in the eyes. Therefore, blocking the binding of VEGF and the corresponding receptor has become critical for inhibiting corneal neovascularization. In this study, we have expressed the cDNA for sFlk-1 under the control of cytomegalovirus immediate-early promoter (CMV) from an E1/partial E3 deleted replication defective recombinant adenovirus, and Ad.sflk-1 expression was determined by Western blotting. We have shown that conditioned media from Ad.sflk-1-infected ARPE-19 cells significantly reduced VEGF-induced human umbilical vein endothelial cells (HUVEC) and murine endothelial cells (SVEC) proliferation in vitro compared with the control vector. In vivo, adenoviral vectors expressing green fluorescent protein alone (Ad.GFP) were utilized to monitor gene transfer to the cornea. Moreover, in the models of corneal neovascularization, the injection of Ad.sflk-1 (10{sup 8} PFU) into the anterior chamber could significantly inhibit angiogenic changes compared with Ad.null-injected and vehicle-injected models. Immunohistochemical analysis showed that corneal endothelial cells and corneal stroma of cauterized rat eyes were efficiently transduced and expressed sFlk-1. These results not only support that adenoviral vectors are capable of high-level transgene expression but also demonstrate that Ad.sflk-1 gene therapy might be a feasible approach for inhibiting the development of corneal neovascularization.

OSTI ID:
21032912
Journal Information:
Biochemical and Biophysical Research Communications, Journal Name: Biochemical and Biophysical Research Communications Journal Issue: 4 Vol. 361; ISSN BBRCA9; ISSN 0006-291X
Country of Publication:
United States
Language:
English

Similar Records

CCL23 up-regulates expression of KDR/Flk-1 and potentiates VEGF-induced proliferation and migration of human endothelial cells
Journal Article · Fri Apr 24 00:00:00 EDT 2009 · Biochemical and Biophysical Research Communications · OSTI ID:22199667

The effect of total-body irradiation on corneal neovascularization in the Fischer 344 rat after chemical cauterization
Journal Article · Sat Jun 01 00:00:00 EDT 1991 · Investigative Ophthalmology and Visual Science; (United States) · OSTI ID:5270954

Comparing protein VEGF inhibitors: In vitro biological studies
Journal Article · Fri May 06 00:00:00 EDT 2011 · Biochemical and Biophysical Research Communications · OSTI ID:22204907